Equity Analysis

Key Financial Ratios
    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    4.1902176
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    9.21
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio8.830.000.000.000.00
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio1.060.540.760.890.94
Fixed Assets0.000.000.000.000.00
Inventory0.000.000.000.000.00
Debtors0.000.000.000.000.00
Interest Cover Ratio0.000.000.000.000.00
PBIDTM (%)0.000.000.000.000.00
PBITM (%)0.000.000.000.000.00
PBDTM (%)0.000.000.000.000.00
CPM (%)0.000.000.000.000.00
APATM (%)0.000.000.000.000.00
ROCE (%)0.000.000.000.000.00
RONW (%)0.000.000.000.000.00